Literature DB >> 1346293

Sudden cardiac tamponade after chemotherapy for marrow transplantation in thalassaemia.

E Angelucci1, E Mariotti, G Lucarelli, D Baronciani, P Cesaroni, S M Durazzi, M Galimberti, C Giardini, P Muretto, P Polchi.   

Abstract

Published work suggests that cardiac tamponade occurs only occasionally after bone-marrow transplantation (BMT) but the worrying number of cases encountered in the transplant programme in Pesaro, Italy, has led to an analysis of this complication. Cardiac tamponade occurred in 8 (2%) of 400 consecutive thalassaemic patients during conditioning for or within a month of BMT. 6 cases were fatal; these represented 9% of all causes of death and 29% of those occurring between start of conditioning regimen and 30 days post transplant. The syndrome was characterised by sudden onset of circulatory shock and cardiac arrest. The only effective treatment was immediate fluid removal. The absence of myocardial lesions and the complete resolution of the syndrome after pericardiocentesis suggest that the pericardial membranes played the main part in the pathogenesis of the syndrome. Since irradiation was not part of the conditioning regimen and since 3 of the affected patients had bacteraemia, the triggering factor for the syndrome could have been the drugs used for conditioning, acting alone or together with bacteraemia and trauma. The frequency with which we encountered the syndrome, and the similarity among our patients in clinical picture, and in characteristics of the effusion, indicate that cardiac tamponade occurring in thalassaemic patients after start of chemotherapy as conditioning for BMT is a specific syndrome requiring rapid treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346293     DOI: 10.1016/0140-6736(92)91343-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Pericardial effusion post transplantation predicts inferior overall survival following allo-hematopoietic stem cell transplant.

Authors:  X Chen; Q Zou; J Yin; C Wang; J Xu; J Wei; Y Zhang
Journal:  Bone Marrow Transplant       Date:  2015-10-19       Impact factor: 5.483

2.  Large pericardial effusion as a complication in adults undergoing SCT.

Authors:  M Norkin; V Ratanatharathorn; L Ayash; M H Abidi; Z Al-Kadhimi; L G Lum; J P Uberti
Journal:  Bone Marrow Transplant       Date:  2010-11-29       Impact factor: 5.483

3.  The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults.

Authors:  S J Rotz; T D Ryan; S Jodele; J L Jefferies; A Lane; A Pate; R Hirsch; J Hlavaty; A E Levesque; M D Taylor; M Cash; K C Myers; J A El-Bietar; S M Davies; C E Dandoy
Journal:  Bone Marrow Transplant       Date:  2017-04-10       Impact factor: 5.483

4.  Dying from cardiac tamponade.

Authors:  Aravind Swaminathan; Karikalan Kandaswamy; Manish Powari; Joseph Mathew
Journal:  World J Emerg Surg       Date:  2007-09-06       Impact factor: 5.469

5.  Factors Affecting Survival in Children With Pericardial Effusion After Hematopoietic Stem Cell Transplantation.

Authors:  Tang-Her Jaing; Shih-Hsiang Chen; Yu-Chuan Wen; Tsung-Yen Chang; Dai-Yun Tsai; Hung-Tao Chung; Pei-Kwei Tsay
Journal:  Cell Transplant       Date:  2017-11       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.